Success Reported With HAE Tx in Severe COVID-19

(MedPage Today) -- Hospitalized COVID-19 patients who received icatibant (Firazyr), the bradykinin inhibitor normally used for hereditary angioedema (HAE), had less need for oxygen supplementation compared to controls, a small retrospective study...